Prognosis of cardiogenic shock secondary to culprit left main coronary artery lesion-related myocardial infarction.

ESC Heart Fail · 2023 · PMC9871657 · PMID 36151843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The SHOCK trial showed a trend towards improvement in 30 day mortality and a significant reduction in 6 month mortality among patients with AMICS undergoing urgent revascularization. 20 Concurrent studies demonstrated an improvement in 30 day mortality in AMICS patients admitted to centres with the possibility of performing

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.